Persistent invisible haematuria with A3 albuminuria — MSRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Refer for specialist nephrology assessment and arrange review of the persistent neutrophilia with appropriate safety-netting
This man has persistent invisible haematuria because 2 of 3 appropriately collected reagent-strip tests are positive. He also has confirmed A3 albuminuria, with ACR persistently above 30 mg/mmol, and haematuria. NICE CKD guidance recommends specialist assessment for adults with ACR above 30 mg/mmol together with haematuria, irrespective of preserved eGFR. Nephrology referral is therefore indicated. He does not meet the NICE suspected cancer pathway criterion for bladder cancer: unexplained non-visible haematuria with either dysuria or raised white cell count requires age 60 years or over. His smoking history and neutrophilia make bladder malignancy an important consideration and justify careful review and safety-netting, but they do not meet this specific urgent referral threshold at age 59. A direct ultrasound is not the recommended substitute for the indicated nephrology referral. Annual monitoring applies to persistent invisible haematuria in the absence of proteinuria; it is inappropriate with confirmed A3 albuminuria. Urine microscopy should not be used to confirm a positive reagent-strip result in this setting.
Reference: NICE NG203: Chronic kidney disease: assessment and management — haematuria and referral criteria (2021; NICE page current when checked August 2026) — https://www.nice.org.uk/guidance/ng203/chapter/Recommendations NICE NG12: Suspected cancer: recognition and referral — bladder cancer recommendation 1.6.4 (2015, amended 2025; NICE page updated 2026) — https://www.nice.org.uk/guidance/ng12/chapter/recommendations-organised-by-site-of-cancer